Neuronal Signaling: an introduction

por Sullivan, Aideen M.
Publicado 2016

Neuronal Signaling: A reflection on the Biochemical Society’s newest journal and an exciting outlook on its next steps

por Sullivan, Aideen M., Stanford, S. Clare
Publicado 2021

Neurotrophic factor therapy for Parkinson's disease: past, present and future

por Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2016

Exercise as therapy for Parkinson's?

por Crowley, Erin K., Nolan, Yvonne M., Sullivan, Aideen M.
Publicado 2018

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease

por Hegarty, Shane V., O’Keeffe, Gerard W., Sullivan, Aideen M.
Publicado 2014

The Epigenome as a therapeutic target for Parkinson's disease

por Hegarty, Shane V., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2016

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2017

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2016

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

por Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2018

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease

por O'Keeffe, Gerard W., Hegarty, Shane V., Sullivan, Aideen M.
Publicado 2017

The class II histone deacetylases as therapeutic targets for Parkinson’s disease

por Mazzocchi, Martina, Collins, Louise M, Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2020

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease

por Costello, Daniel J, O'Keeffe, Gerard W, Hurley, Fiona M, Sullivan, Aideen M
Publicado 2012

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease

por Goulding, Susan R., Sullivan, Aideen M., O'Keeffe, Gerard W., Collins, Louise M.
Publicado 2020

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease

por Hegarty, Shane V., Green, Holly F., Niclis, Jonathan, O'Keeffe, Gerard W., Sullivan, Aideen M.
Publicado 2020

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease

por Goulding, Susan R., Anantha, Jayanth, Collins, Louise M., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2021

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study

por Dunk, Danielle, Mulryan, Philip, Affonso, Sean, O’Keeffe, Gerard W., O’Keeffe, Majella, Sullivan, Aideen M.
Publicado 2022

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells

por Alshangiti, Amnah M., Togher, Katie L., Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2019

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation

por Hegarty, Shane V., Wyatt, Sean L., Howard, Laura, Stappers, Elke, Huylebroeck, Danny, Sullivan, Aideen M., O’Keeffe, Gerard W.
Publicado 2017

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells

por Alshangiti, Amnah M., Tuboly, Eszter, Hegarty, Shane V., McCarthy, Cathal M., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2019

STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5

por Anantha, Jayanth, Goulding, Susan R., Wyatt, Sean L., Concannon, Ruth M., Collins, Louise M., Sullivan, Aideen M., O'Keeffe, Gerard W.
Publicado 2020